TALECRIS VISION
CORPORATE SITES
Talecris Canada
Talecris Europe
Talecris United States
Talecris International
View All
PRODUCT SITES
Alpha-1 Antitrypsin Deficiency
Immune Globulin Intravenous
Therapy
PROGRAMS & SERVICES
Contract Manufacturing Services
CONTACT TALECRIS
Europe |
Deutsch
Home
About Talecris Europe
Talecris Innovations
Media Center
Media Center
Media Center - Europe
If you are a member of the media and would like to speak to someone in our Corporate Communications department, please call our media line at (+1) 919-316-6316.
Inquiries from journalists only please.
RECENT PRESS RELEASES
:
April 07, 2008
Die vom global agierenden Biotechnologieunternehmen Talecris Biotherapeutics, Inc. finanzierte „ICE-Studie“ ist die bislang größte veröffentlichte
September 16, 2007
Talecris Biotherapeutics awards Winners of the 4th European ALTA Fellowship Program
August 27, 2007
Talecris-Sponsored Scientific Symposium Examines Advances in Use of Intravenous Immune Globulin for Neurological Disorders
May 08, 2007
Talecris Biotherapeutics’ Talents Program Accepting Applications for 2007 Research Grant Awards
February 01, 2007
Talecris Biotherapeutics supports projects in the field of Alpha-1-Antitrypsin Deficiency with eALTA fellowships
Learn more about Talecris Biotherapeutics, contact Talecris, and request Talecris updates.
Contact Talecris
Glossary
Site Map
General Conditions of Use
Privacy Statement
Imprint
© 2008 Talecris Biotherapeutics
